| Item Type | Name |
|
Academic Article
|
Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein.
|
|
Academic Article
|
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
|
|
Academic Article
|
Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy.
|
|
Academic Article
|
Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women.
|
|
Academic Article
|
Hormone replacement therapy and heart disease: replacing dogma with data.
|
|
Academic Article
|
Role of estrogen receptor-alpha in pharmacogenetics of estrogen action.
|
|
Academic Article
|
ER-alpha variants and the cardiovascular effects of hormone replacement therapy.
|
|
Academic Article
|
Fracture and the risk of coronary events in women with heart disease.
|
|
Academic Article
|
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002 : Section 4: lessons from hormone replacement trials.
|
|
Academic Article
|
Pulse pressure and coronary atherosclerosis progression in postmenopausal women.
|
|
Academic Article
|
Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
|
|
Academic Article
|
Effects of oestrogen receptor-active compounds on lipid metabolism.
|
|
Academic Article
|
Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.
|
|
Academic Article
|
Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
|
|
Academic Article
|
Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.
|
|
Academic Article
|
Comprehensive evaluation of the estrogen receptor alpha gene reveals further evidence for association with type 2 diabetes enriched for nephropathy in an African American population.
|
|
Academic Article
|
Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Adherence to 2005 Dietary Guidelines for Americans is associated with a reduced progression of coronary artery atherosclerosis in women with established coronary artery disease.
|
|
Academic Article
|
Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women.
|
|
Academic Article
|
Estrogen receptor polymorphisms and the vascular effects of hormone therapy.
|
|
Academic Article
|
Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned.
|
|
Academic Article
|
Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease.
|
|
Academic Article
|
Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).
|
|
Academic Article
|
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
|
|
Academic Article
|
Baseline health-related quality of life in postmenopausal women with coronary heart disease: the Estrogen Replacement and Atherosclerosis (ERA) trial.
|
|
Academic Article
|
From presumed benefit to potential harm--hormone therapy and heart disease.
|
|
Academic Article
|
Effects of conjugated oestrogen and droloxifene on the renin-angiotensin system, blood pressure and renal blood flow in postmenopausal women.
|
|
Academic Article
|
The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: the postmenopausal estrogen progestin intervention (PEPI) trial.
|
|
Academic Article
|
Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women.
|
|
Academic Article
|
Progestins affect mechanism of estrogen-induced C-reactive protein stimulation.
|
|
Academic Article
|
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative.
|
|
Academic Article
|
Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative.
|
|
Academic Article
|
Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
|
|
Academic Article
|
Changes in remnant and high-density lipoproteins associated with hormone therapy and progression of coronary artery disease in postmenopausal women.
|
|
Academic Article
|
Submaximal exercise coronary artery flow increases in postmenopausal women without coronary artery disease after estrogen and atorvastatin.
|
|
Academic Article
|
Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status.
|
|
Concept
|
Estrogen Replacement Therapy
|
|
Concept
|
Estrogens
|
|
Concept
|
Selective Estrogen Receptor Modulators
|
|
Concept
|
Estrogens, Conjugated (USP)
|
|
Concept
|
Estrogen Receptor beta
|
|
Concept
|
Receptors, Estrogen
|
|
Concept
|
Estrogen Receptor alpha
|
|
Grant
|
Estrogen Receptor Variance and CHD Risk in HERS
|
|
Grant
|
Thrombosis Gene Polymorphisms and Early CHD Risk in HERS
|
|
Grant
|
ESTROGEN AND ATHEROSCLEROSIS--UPDATE 96
|
|
Grant
|
Estrogen Receptor Variants,HDL, and Atherosclerosis
|
|
Grant
|
ESTROGEN REPLACEMENT AND ATHEROSCLEROSIS IN OLDER WOMEN
|
|
Grant
|
GRAYLYN CONFERENCE ON WOMEN'S HEALTH
|
|
Grant
|
ESTROGEN, INFLAMMATION AND ATHEROSCLEROSIS
|